Chromogranin A-activated microglial cells induce neuronal apoptosis

Gabrielle Ulrich1, Jaroslava Ciesielski-Treska, Laurent Taupenot

  • 1CNRS UPR-2356 Neurotransmission et Secretion Neuroendocrine 5, 67084 Strasbourg Cedex, France.

Insights

Chromogranin (CgA) activates microglia, causing neuronal death via Fas and p38 MAP kinase pathways. This suggests CgA is a key inflammatory factor in neurodegeneration.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Chromogranin (CgA) is elevated in various neuropathologies.
  • Microglial activation contributes to neuronal damage in neurological diseases.

Purpose of the Study:

  • To investigate the role of Chromogranin (CgA) in microglial activation and subsequent neuronal apoptosis.
  • To elucidate the specific death-signaling pathways involved in CgA-induced neurodegeneration.

Main Methods:

  • The study likely involved in vitro or in vivo models to examine CgA's effects on microglial cells and neurons.
  • Analysis of cell death markers, signaling pathway activation (e.g., Western blotting for p38 MAP kinase, Fas), and mitochondrial function.

Main Results:

  • Chromogranin (CgA) was found to induce an activated phenotype in microglial cells.
  • This microglial activation led to neuronal apoptosis (programmed cell death).
  • The neuronal death signaling involved the Fas receptor, p38 MAP kinase, and mitochondrial cytochrome c release.

Conclusions:

  • Chromogranin (CgA) acts as a potent endogenous inflammatory factor.
  • CgA contributes significantly to neuronal degeneration in neuropathological conditions.
  • Targeting CgA or its downstream pathways may offer therapeutic strategies for neurodegenerative diseases.